Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 118

Sort by

Sort Order Select

Journal Articles

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Gerben Duns, PhD, Elena Viganò, PhD, Daisuke Ennishi, MD PhD, Clementine Sarkozy, MD, Stacy Hung, Elizabeth Chavez, Katsuyoshi Takata, MD PhD, Anja Mottok, MD PhD, Randy D. Gascoyne, MD, Ryan D. Morin, PhD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 922.

https://doi.org/10.1182/blood-2019-131450

Published: 2019

Journal Articles

Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Giovanni Caocci, MD, Martino Deidda, Antonio Noto, Christian Cadeddu, Marianna Greco, Maria Pina Simula, Olga Mulas, Daniele Cocco, Claudia Fattuoni, Giuseppe Mercuro, Giorgio La Nasa

Blood (2019) 134 (Supplement_1): 4144.

https://doi.org/10.1182/blood-2019-124323

Published: 2019

Journal Articles

Dose Optimization in Elderly CML Patients Treated with Bosutinib after Intolerance or Failure of First-Line Tyrosine Kinase Inhibitors

Blood (2019) 134 (Supplement_1): 496.

https://doi.org/10.1182/blood-2019-127514

Published: 2019

Journal Articles

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Rong-Fu Zhou, PhD MD, WANG JUN, MD, Xu Peng, MD, Hui Zeng, MD, Yong Xu, PhD, Yueyi Xu, MD, Min Zhou, Peipei Xu, Bing Chen

Blood (2019) 134 (Supplement_1): 4947.

https://doi.org/10.1182/blood-2019-130459

Published: 2019

Journal Articles

Relapse of multiple myeloma presenting as pericardial effusion

Justine Onraed, Thomas Boyer

Blood (2019) 133 (6): 619.

https://doi.org/10.1182/blood-2018-11-884221

Published: 2019

Journal Articles

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Vickie Marshall, Nazzarena Labo, MD PhD, Anaida Widell, Matthew Lindsley, Mark N. Polizzotto, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 4137.

https://doi.org/10.1182/blood-2018-99-117668

Published: 2018

Journal Articles

Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I Study

Jonathan Webster, MD, Marlise R. Luskin, MD, Gabrielle T. Prince, MD, Amy E. DeZern, MD, Daniel J. DeAngelo, MD, Mark J. Levis, MD, Amanda Blackford, Elad Sharon, MD MPH, Howard Streicher, MD, Leo Luznik, MD, Ivana Gojo, MD

Blood (2018) 132 (Supplement 1): 557.

https://doi.org/10.1182/blood-2018-99-111845

Published: 2018

Journal Articles

Kaposiform Lymphangiomatosis: Update on Outcomes and Use of Sirolimus As a Therapeutic Intervention

Whitney Eng, MD, Hasan Al-Sayegh, Clement Ma, PhD, Denise Adams, MD

Blood (2018) 132 (Supplement 1): 3734.

https://doi.org/10.1182/blood-2018-99-110989

Published: 2018

Journal Articles

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Lianna J. Marks, Kathleen M. McCarten, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly

Blood (2018) 132 (11): 1208–1211.

https://doi.org/10.1182/blood-2018-02-834465

Published: 2018

Journal Articles

Mature Analysis of the Prospective Oxford Down Syndrome (DS) Cohort Study: Timing and Clinical Impact of Preleukemic GATA1 Mutations and Lessons for Management of Newborns with DS

Irene Roberts, MD, Neha Bhatnagar, ND, Amelie Chaussade, MD, Laure Nizery, MD, Helen Richmond, RSCN, Natalina Elliott, PhD, Gemma Buck, BSc, Marlen Metzner, MSc, Alison Kennedy, MSc, Catherine Garnett, Kelly Perkins, PhD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath

Blood (2017) 130 (Supplement 1): 569.

https://doi.org/10.1182/blood.V130.Suppl_1.569.569

Published: 2017

Journal Articles

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Mahesh Swaminathan, MD, Hagop M. Kantarjian, MD, Naval Daver, MD, Gautam Borthakur, MD, Maro Ohanian, DO, Tapan Kadia, MD, Courtney D. DiNardo, MDMSc, Nitin Jain, MD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, William G Wierda, MD PhD, Farhad Ravandi, MBBS, Maria Rhona Pinsoy, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 723.

https://doi.org/10.1182/blood.V130.Suppl_1.723.723

Published: 2017

Journal Articles

Understanding the Transferrin Receptor and Cellular Iron Deficiency Outside the Erythron

Nancy C. Andrews, MD PhD

Blood (2017) 130 (Supplement 1): SCI-42.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-42.SCI-42

Published: 2017

Journal Articles

Long-Term Cardiac, Vascular and Hypertensive Safety of Bosutinib in Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia Resistant or Intolerant to Prior Therapy

Jorge E. Cortes, MD, Dong-Wook Kim, MD PhD, Hagop M. Kantarjian, MD, Michael J. Mauro, MD, Jean M. Aguiar, RN, Fiona An, MD, Eric Leip, PhD, Carlo Gambacorti-Passerini, MD, Tim H. Brummendorf, MD

Blood (2017) 130 (Supplement 1): 1590.

https://doi.org/10.1182/blood.V130.Suppl_1.1590.1590

Published: 2017

Journal Articles

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Vamsi Kota, MBBS, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Sheldon Bolds, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 5017.

https://doi.org/10.1182/blood.V130.Suppl_1.5017.5017

Published: 2017

Journal Articles

Targeting Systemic Inflammatory Response Syndrome As Initial Therapy and Oral Arsenic Based Consolidation Regimen for Acute Promyelocytic Leukemia

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 1333.

https://doi.org/10.1182/blood.V130.Suppl_1.1333.1333

Published: 2017

Journal Articles

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Ellen K. Ritchie, MD, Rose Catchatourian, MD, Rebecca B Klisovic, MD, Javier Pinilla-Ibarz, MD PhD, Michael W. Deininger, MD PhD, Harry P. Erba, MD PhD, Jerald P. Radich, Michael R. Savona, MD, Ilva Dautaj, MS, Johannes Wolff, MD, Michael J. Mauro, MD

Blood (2016) 128 (22): 3090.

https://doi.org/10.1182/blood.V128.22.3090.3090

Published: 2016

Journal Articles

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

Kasiani C. Myers, MD, Sonata Jodele, MD, Adam S. Nelson, MBBS, Erica Goodridge, Parinda A Mehta, MD, Robin Mueller, Christopher E. Dandoy, MD, Adam Lane, PhD, Javier A. El-Bietar, MD, Stella M Davies, MBBS, PhD

Blood (2016) 128 (22): 2217.

https://doi.org/10.1182/blood.V128.22.2217.2217

Published: 2016

Journal Articles

Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study

Chikashi Yoshida, MD PhD, Noriyoshi Iriyama, MDPhD, Yuho Najima, Shin Fujisawa, MD PhD, Hisashi Wakita, MD PhD, Shigeru Chiba, MD, PhD, Shinichiro Okamoto, MD PhD, Kimihiro Kawakami, MDPhD, Naoki Takezako, MD PhD, Takashi Kumagai, MD PhD, Kazuma Ohyashiki, MD PhD, Jun Taguchi, MD PhD, Shingo Yano, MD PhD, Tadahiko Igarashi, MD, Yasuji Kouzai, MD PhD, Satoshi Morita, PhD Prof, Junichi Sakamoto, MD PhD, Hisashi Sakamaki, MD PhD, Koiti Inokuchi, MD PhD Prof

Blood (2016) 128 (22): 1916.

https://doi.org/10.1182/blood.V128.22.1916.1916

Published: 2016

Journal Articles

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Manuel Ayala, MD, Jacqueline Domínguez, NL, Iván Bonilla, MD

Blood (2016) 128 (22): 5430.

https://doi.org/10.1182/blood.V128.22.5430.5430

Published: 2016

Journal Articles

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Yasser Khaled, MD, George Yaghmour, MD, Christy R Parks, FNP, Deborah Lamontagne, MLS(ASCP)CM, Joshua Boss, RN, Diwura Owolabi, PharmD, BCOP, Sallyanne C. Fossey, PhD, Lisa Murphy, MT(ASCP), Robert Bradley, MD

Blood (2016) 128 (22): 3431.

https://doi.org/10.1182/blood.V128.22.3431.3431

Published: 2016

NARROW

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Dose Optimization in Elderly CML Patients Treated with Bosutinib after Intolerance or Failure of First-Line Tyrosine Kinase Inhibitors

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Relapse of multiple myeloma presenting as pericardial effusion

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I Study

Kaposiform Lymphangiomatosis: Update on Outcomes and Use of Sirolimus As a Therapeutic Intervention

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Mature Analysis of the Prospective Oxford Down Syndrome (DS) Cohort Study: Timing and Clinical Impact of Preleukemic GATA1 Mutations and Lessons for Management of Newborns with DS

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Understanding the Transferrin Receptor and Cellular Iron Deficiency Outside the Erythron

Long-Term Cardiac, Vascular and Hypertensive Safety of Bosutinib in Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia Resistant or Intolerant to Prior Therapy

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Targeting Systemic Inflammatory Response Syndrome As Initial Therapy and Oral Arsenic Based Consolidation Regimen for Acute Promyelocytic Leukemia

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only